Form 4: Geron Corp Director Robert J. Spiegel Acquires 180,000 Stock Options
SEC Form 4
Director Robert J. Spiegel reports acquisition of 180,000 stock options in Geron Corporation.
Summary
- Robert J. Spiegel, a director of Geron Corporation, filed a Form 4 with the SEC.
- The form reports the acquisition of 180,000 stock options on May 9, 2024.
- The exercise price of the options is $3.88.
- The options vest on the earlier of the next annual meeting of the company's stockholders or the first anniversary of the grant date (May 9, 2025), contingent upon continuous service as a non-employee director.
- The options expire on May 8, 2034.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of stock option acquisition by a director. While insider confidence is generally positive, this is a routine transaction.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The vesting of the options is contingent upon the director's continuous service with the company.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 05/09/2024 | Date of transaction: Acquisition of 180,000 stock options. |
| 05/09/2025 | Earliest possible vesting date of the options (first anniversary of grant date). |
| 05/08/2034 | Expiration date of the stock options. |
| 05/10/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.